Buy Aarti Drugs, target price Rs 536 Axis Securities - The Economic Times
| AARTIDRUGS | 428.25 3.65 0.85% |
Slightly above 62% of Aarti Drugs' investor base is looking to short. The analysis of overall sentiment of trading Aarti Drugs Limited stock suggests that many investors are alarmed at this time. Aarti Drugs' investing sentiment overview a quick insight into current market opportunities from investing in Aarti Drugs Limited. Many technical investors use Aarti Drugs Limited stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aarti Drugs stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Aarti daily returns and investor perception about the current price of Aarti Drugs Limited as well as its diversification or hedging effects on your existing portfolios.
Aarti |
Buy Aarti Drugs, target price Rs 536 Axis Securities The Economic Times
Read at news.google.com
 |
Aarti Drugs Fundamental Analysis
We analyze Aarti Drugs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aarti Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aarti Drugs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Aarti Drugs is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Aarti Drugs Limited Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aarti Drugs stock to make a market-neutral strategy. Peer analysis of Aarti Drugs could also be used in its relative valuation, which is a method of valuing Aarti Drugs by comparing valuation metrics with similar companies.
Peers
Aarti Drugs Related Equities
| KINGFA | Kingfa Science | 3.71 | ||||
| GATECHDVR | GACM Technologies | 1.03 | ||||
| HEUBACHIND | Heubach Colorants | 0.50 | ||||
| CHEMCON | Chemcon Speciality | 1.54 | ||||
| PARAGMILK | Parag Milk | 1.83 | ||||
| RICOAUTO | Rico Auto | 2.90 | ||||
| TBZ | Tribhovandas Bhimji | 3.31 | ||||
| COSMOFIRST | COSMO FIRST | 3.33 | ||||
| DELTAMAGNT | Delta Manufacturing | 3.44 | ||||
| ARVIND | Arvind | 4.85 |
Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.